Only CD62L+CD4+CD25+ Tregs prevent severe tissue damage to the colon and protected from lethal GvHD [20] by inhibition of the expansion of donor derived activated CD4+CD25- T cells. This evidence concerns the gene SELL and graft versus host disease.